Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2297

Journal of Obesity & Weight Loss Therapy received 2297 citations as per Google Scholar report

Journal of Obesity & Weight Loss Therapy peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Centre for Agriculture and Biosciences International (CABI)
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • CABI full text
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • University of Bristol
  • Pubmed
  • ICMJE
Share This Page

Why did we not be able to halve the concomitant pandemics of obesity, diabetes and coronary heart disease?

3rd International Conference and Exhibition on Obesity & Weight Management

Jose Mario F de Oliveira

Universidade Federal Fluminense, Brazil

ScientificTracks Abstracts-Workshop: J Obes Weight Loss Ther

DOI: 10.4172/2165-7904.C1.020

Abstract
The pandemics of obesity and its complications like diabetes, and coronary heart disease, not to mention other diseases like cancer, hypertension, and chronic kidney diseases could well be defined as a modern plague largely brought on by. The panacea of Non-Communicable Diseases has been the biggest drug industry�s win with polypharmacy based namely on poorly surrogates outcomes easily achieved on short-term or biased clinical trials, such as pre-hypertension, microalbuminuria, carotid intima thickness and etc... The complexities of promoting healthy diets and healthy lifestyles even at the workplaces, and childhood are reduced to policies of �Overdiagnosis, Overtreatment and Polyphramacy under the Paradigm of �The Lower the Better��, with the artificial creation of �new�� diseases like �pre-hypertension� and �pre-diabetes�. For this so close companions as Obesity, Type 2 Diabetes, and Coronary Heart Disease the affluent evidence points against intensive glycaemic control in diabetes, useless for micro, and macrovascular disease, these last ones the most disabling and more prevalent obese and diabetic complications. Recent Evidence, also points to less polypharmacy for hypertension and dyslipidaemia (JNC8th Hypertension Report and The BMJ Criticism to the New US Statins Guidelines). And Finally, Healthy Lifestyles, and Diets with at most 5% or less of Sugar daily consumption also should make easier the fight against all these Non-Communicable Diseases like the pandemics of Obesity, Diabetes, and Coronary Heart Disease.
Biography

Jose Mario Franco de Oliveira, MD, PhD is an Associate Professor of Medicine in the Department of Medicine of Universidade Federal Fluminense, in the State of Rio de Janeiro, Brazil. He is a Certified, Nephrologist, Preventative Cardiologist, and Adult Intensive Care Unit Physician. He has published numerous articles and letters to the editor in journals like The New England Journal of Medicine, The British Medical Journal, Hypertension, American Journal of Hypertension, Journal of the American Society of Nephrology, and etc. He is also a reviewer for a number of journals & a Deputy Editor for Diabetes at The British Medical Journal.

Email: jmariofranco@gmail.com

Relevant Topics
Top